PL4404774T3 - System dostarczania składnika aktywnego - Google Patents

System dostarczania składnika aktywnego

Info

Publication number
PL4404774T3
PL4404774T3 PL22778030.1T PL22778030T PL4404774T3 PL 4404774 T3 PL4404774 T3 PL 4404774T3 PL 22778030 T PL22778030 T PL 22778030T PL 4404774 T3 PL4404774 T3 PL 4404774T3
Authority
PL
Poland
Prior art keywords
active ingredient
delivery system
ingredient delivery
active
ingredient
Prior art date
Application number
PL22778030.1T
Other languages
English (en)
Inventor
Janne JÄRVENPÄÄ
Original Assignee
Opes Corporation Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opes Corporation Oy filed Critical Opes Corporation Oy
Publication of PL4404774T3 publication Critical patent/PL4404774T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
    • A24B15/303—Plant extracts other than tobacco
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B3/00—Preparing tobacco in the factory
    • A24B3/14—Forming reconstituted tobacco products, e.g. wrapper materials, sheets, imitation leaves, rods, cakes; Forms of such products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL22778030.1T 2021-09-20 2022-09-20 System dostarczania składnika aktywnego PL4404774T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163246089P 2021-09-20 2021-09-20
PCT/FI2022/050629 WO2023041848A1 (en) 2021-09-20 2022-09-20 Active ingredient delivery system

Publications (1)

Publication Number Publication Date
PL4404774T3 true PL4404774T3 (pl) 2025-06-16

Family

ID=83690055

Family Applications (1)

Application Number Title Priority Date Filing Date
PL22778030.1T PL4404774T3 (pl) 2021-09-20 2022-09-20 System dostarczania składnika aktywnego

Country Status (22)

Country Link
US (1) US20240269087A1 (pl)
EP (2) EP4537678A1 (pl)
JP (2) JP7710264B2 (pl)
KR (1) KR20240072188A (pl)
CN (1) CN118201503A (pl)
AU (3) AU2022346938B2 (pl)
CA (1) CA3232535A1 (pl)
CL (3) CL2024000812A1 (pl)
DK (1) DK4404774T3 (pl)
ES (1) ES3030034T3 (pl)
FI (1) FI4404774T3 (pl)
HR (1) HRP20250464T1 (pl)
HU (1) HUE071598T2 (pl)
IL (1) IL311530A (pl)
LT (1) LT4404774T (pl)
MA (1) MA64901A1 (pl)
MX (1) MX2024003414A (pl)
PL (1) PL4404774T3 (pl)
PT (1) PT4404774T (pl)
RS (1) RS66724B1 (pl)
SI (1) SI4404774T1 (pl)
WO (1) WO2023041848A1 (pl)

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800903A (en) * 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
US6136297A (en) * 1997-06-06 2000-10-24 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
JP2000319167A (ja) * 1999-05-12 2000-11-21 Nitto Denko Corp 口腔内貼付シート
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
EA012306B1 (ru) * 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
SE0301244D0 (sv) 2003-04-29 2003-04-29 Swedish Match North Europe Ab Smokeless tobacco product user package
US20050066463A1 (en) 2003-09-25 2005-03-31 Brunner Michael S. Substrates and devices for applying a lip care formulation
US8469036B2 (en) * 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
SE0402258D0 (sv) * 2004-05-07 2004-09-17 Katarina Saend Portionssnus
EP1758554A1 (en) * 2004-06-12 2007-03-07 Passion For Life Healthcare Limited Soluble strip for oral or topical adminstration
US9044049B2 (en) 2005-04-29 2015-06-02 Philip Morris Usa Inc. Tobacco pouch product
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
DE102008014533A1 (de) * 2008-03-15 2009-09-17 Lts Lohmann Therapie-Systeme Ag Gingival-Wafer
US9027567B2 (en) * 2008-12-30 2015-05-12 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
US8747562B2 (en) * 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
BR112013002861A2 (pt) * 2010-08-05 2016-06-07 Altria Client Services Inc tecido tendo tabaco emaranhado com fibras estruturais
JP2015511970A (ja) 2012-01-11 2015-04-23 オーペーエーエス コーポレイション オサケユイチア 芳香性化合物を含む芳香性製剤
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
WO2014150967A1 (en) * 2013-03-15 2014-09-25 Altria Client Services Inc. Oral energy products including encapsulated caffeine
WO2014188079A1 (en) 2013-05-23 2014-11-27 Åbo Akademi University Printed dosage forms
WO2014198999A1 (en) 2013-06-13 2014-12-18 Opes Corporation Oy Matrix
US20160192703A1 (en) * 2015-01-07 2016-07-07 R.J. Reynolds Tobacco Company Oral pouch products
MX2017010872A (es) * 2015-02-27 2018-05-07 Ebbu Llc Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.
EP3192380B1 (en) * 2016-01-12 2020-11-11 Swedish Match North Europe AB Oral pouched product
EP3644771A4 (en) * 2017-06-26 2021-11-17 Nude Nicotine, Inc. NICOTINE SALT AND METHOD FOR MANUFACTURING AND USING THEREOF
CN107874324A (zh) * 2018-01-07 2018-04-06 张宇 一种尼古丁纸质纤维素载体及制作方法
KR101998288B1 (ko) * 2018-03-09 2019-07-09 (주)씨엘팜 무연 담배용 조성물 및 이를 포함하는 구강 용해 필름형 무연 담배
DE102019117310A1 (de) * 2019-06-27 2020-12-31 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung von Wirkstoffverabreichungssystemen mittels Tampondruckverfahren
US20220331263A1 (en) 2019-09-04 2022-10-20 Vitiprints, LLC Printed Delivery Device Having Supplements
RU2745039C1 (ru) * 2019-11-22 2021-03-18 Кирилл Вадимович Альтшуллер Никотинсодержащая съедобная бумага
EP4072851A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Layered fleece for pouched product
EP4106556A1 (en) * 2020-02-18 2022-12-28 Nerudia Limited Smokeless article
EP3874970A1 (en) * 2020-03-03 2021-09-08 Reemtsma Cigarettenfabriken GmbH Filling material for an oral pouched smokeless product and oral pouched smokeless product manufactured therefrom

Also Published As

Publication number Publication date
CN118201503A (zh) 2024-06-14
KR20240072188A (ko) 2024-05-23
ES3030034T3 (en) 2025-06-26
US20240269087A1 (en) 2024-08-15
LT4404774T (lt) 2025-05-12
HRP20250464T1 (hr) 2025-06-06
PT4404774T (pt) 2025-04-14
JP2024535059A (ja) 2024-09-26
SI4404774T1 (sl) 2025-06-30
RS66724B1 (sr) 2025-05-30
CL2025001049A1 (es) 2025-08-08
CL2024000812A1 (es) 2024-11-22
EP4404774B1 (en) 2025-02-12
AU2022346938B2 (en) 2025-05-29
DK4404774T3 (da) 2025-04-07
JP2025122079A (ja) 2025-08-20
EP4404774A1 (en) 2024-07-31
MA64901A1 (fr) 2024-11-29
AU2025213655A1 (en) 2025-08-28
FI4404774T3 (fi) 2025-05-06
JP7710264B2 (ja) 2025-07-18
MX2024003414A (es) 2024-05-10
CL2025001048A1 (es) 2025-08-08
EP4537678A1 (en) 2025-04-16
AU2025213645A1 (en) 2025-08-28
WO2023041848A1 (en) 2023-03-23
CA3232535A1 (en) 2023-03-23
HUE071598T2 (hu) 2025-09-28
AU2022346938A1 (en) 2024-04-11
IL311530A (en) 2024-05-01

Similar Documents

Publication Publication Date Title
CA215994S (en) Drug delivery system
CA215995S (en) Drug delivery system
CA215997S (en) Drug delivery system
PL4424233T3 (pl) System dostarczania leku w postaci rozpylonej
GB202004701D0 (en) Delivery system
GB202008130D0 (en) Delivery system
IL291539A (en) Biocompatible polymeric drug carriers for delivery of active substances
GB202008120D0 (en) Delivery system
LT4404774T (lt) Veikliosios medžiagos tiekimo sistema
IL313377A (en) Delivery system
IL291283A (en) Formulations for drug delivery
GB202108686D0 (en) Game delivery system
GB202004707D0 (en) Delivery system
GB202004731D0 (en) Delivery system
GB202004730D0 (en) Delivery system
GB202004702D0 (en) Delivery system
CA230715S (en) Drug delivery system
GB202213668D0 (en) Improved drug delivery systems
IL313381A (en) transfer system
ZA202105940B (en) Drug delivery system
GB202113045D0 (en) Delivery System
GB202110543D0 (en) Delivery system
GB202110541D0 (en) Delivery system
GB202110546D0 (en) Delivery system
GB202104593D0 (en) Delivery system